Gene Query: SYMPK

Dataset Description Geneva Score
HEXIM1 is induced by DHODH inhibition to suppress melanoma 59.0
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 59.0
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 41.3
MOF acetyl transferase regulates transcription and respiration in mitochondria 26.15
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 22.2
DART-seq: an antibody-free method for global m6A detection 21.75
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 21.51
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 20.93
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 20.45
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 20.37
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 19.65
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 19.65
RNA-sequencing in irradiated and normal A549 cells. 19.43
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 18.15
Primary human trophoblast from term placenta 18.12
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 17.89
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 16.54
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 16.34
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 16.08
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 15.49
Hepatitis C virus functionally sequesters miR-122 15.49
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 15.3
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 15.21
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 15.15
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 14.24
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 14.21
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 14.15
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 13.75
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 13.75
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 13.7
The interplay between SOX4 and SMAD3 in the context of breast cancer 13.59
Transcriptional profiling of microglia; current state of the art and future perspectives 13.14
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 12.68
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 12.68
Studying the selectivity of a small molecule Synucleozid on transcriptome 12.24
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 12.0
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 11.65
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 11.65
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 11.51
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 11.4
High-throughput sequencing of pluripotent cells 11.39
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 11.38
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 11.38
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 11.28
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 11.13
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 11.13
Landscape and variation of RNA secondary structure across the human transcriptome 10.47
Regulation of highly expressed hCINAP on translatome 10.24
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 10.2
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.78
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 9.59
The effect of PPARG inhibition on human angiomyolipoma cells 9.53
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 9.53
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 9.52
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 9.52
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 9.5
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.4
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 9.35
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 9.35
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 9.28
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 9.28
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 9.25
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 9.15
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 9.02
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 8.93
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 8.89
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 8.76
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 8.63
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.57
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.57
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 8.55
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 8.54
ARID1A and ARID1B loss in HCT116 and TOV21G cells 8.45
Role of XRN2 ribonucleolytic activity in RNA metabolism 8.42
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 8.41
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 8.4
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 8.38
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 8.36
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 8.31
HEK293 TFAM Knockout Expression Study 8.31
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 8.27
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 8.24
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 8.22
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 8.22
Disruption of the exocyst induces podocyte loss and dysfunction 8.16
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 8.15
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 8.14
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 8.06
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 8.06
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 8.02
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 7.96
Identification of long noncoding RNAs regulated by p53 7.92
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 7.82
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 7.76
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 7.65
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 7.6
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 7.58
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 7.55
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 7.55
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 7.54
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 7.54
Differential gene expression profiles in imatinib-resistant cell lines 7.46
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 7.37
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 7.24
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 7.24
Tracking of dCas9-methyltransferase footprints 7.22
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 7.16
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 7.1
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 7.1
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 7.08
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 7.08
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 7.07
TFAP2C signalling in human fibroblasts 7.0
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 6.98
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.93
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.93
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.9
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 6.85
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 6.84
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 6.79
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 6.78
Expression and functions of long noncoding RNAs during human T helper cell differentiation 6.77
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 6.73
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 6.69
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 6.66
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 6.64
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 6.61
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 6.59
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 6.59
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 6.56
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 6.55
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 6.5
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 6.5
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 6.5
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 6.49
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 6.4
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 6.35
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 6.31
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 6.31
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 6.3
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 6.27
Small-molecule targeting of brachyury transcription factor addiction in chordoma 6.26
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 6.21
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 6.19
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 6.18
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 6.16
Intrahepatic MAIT cell gene expression revealed by RNA-seq 6.13
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 6.12
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 6.08
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 6.07
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.03
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 6.01
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 5.97
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 5.96
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 5.96
A549 cells and MSR-A549 cells 5.96
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.92
Regulation of poly(A) tail and translation during the somatic cell cycle 5.89
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.89
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 5.87
Universal alternative splicing of noncoding exons 5.83
Effect of BB608 on Gene Expression in HNSCC Cell Line 5.8
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 5.79
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 5.77
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.72
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.72
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 5.7
H1609088 Human RNA-Sequencing 5.63
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 5.63
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 5.63
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 5.62
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 5.61
Total RNA-seq in ALL-SIL upon TLX1 knockdown 5.6
N6-methyladenine DNA Modification in Glioblastoma 5.59
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 5.59
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 5.59
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 5.52
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 5.49
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 5.46
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 5.45
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 5.43
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 5.43
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 5.41
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  5.4
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 5.38
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 5.34
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 5.3
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 5.29
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 5.29
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 5.28
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 5.27
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 5.26
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 5.24
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 5.23
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 5.22
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 5.22
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.21
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 5.18
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 5.15
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 5.15
Cajal bodies are linked to genome conformation [RNA-Seq] 5.14
Cajal bodies are linked to genome conformation 5.14
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.12
RNA sequencing of primary human platelets and in vitro cell lines 5.09
Searching for target genes of miR-508/509/506/514 in HCT116 cells 5.08
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 5.06
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 5.05
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 5.0
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 5.0
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 5.0
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 4.99
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.99
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.98
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.98
Tracking distinct RNA populations using efficient and reversible covalent chemistry 4.95
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 4.89
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 4.88
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 4.83
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.78
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 4.76
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.75
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.75
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 4.69
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 4.69
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 4.65
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 4.62
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 4.51
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 4.33
Global response to chemotherapy-induced apoptosis 4.28
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.21
mRNA recovered upon RNF219 IP. [RNA-IP] 4.19
mRNA-Seq profiling of human developing kidney 4.16
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 4.12
Global analyses of the effect of different cellular contexts on microRNA targeting 4.12
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 4.11
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.1
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 4.1
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 4.05
RNA polymerase in pre-B-ALL cell lines 4.04
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 4.02
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 4.01
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 3.98
METTL3 and WTAP 3.97
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 3.96
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 3.95
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 3.95
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.86
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.84
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.81
Gene expression profile in breast cancer cells 3.81
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.79
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 3.78
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 3.75
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 3.72
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 3.69
X-Ray induced DNA-Hydroxymethylation changes 3.68
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 3.67
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 3.65
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.64
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 3.64
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 3.64
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 3.62
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 3.61
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.58
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.52
An integrative analysis of non-coding regulatory DNA variations associated with autism 3.5
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 3.39
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 3.31
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 3.31
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 3.27
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 3.27
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 3.26
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 3.26
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 3.25
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 3.24
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.2
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 3.18
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 3.18
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.18
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.18
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 3.18
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 3.16
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 3.15
Gene expression changes due to PARP knockdown in human cells 3.15
Ectoderm specification of H1 human embryonic stem cells 3.13
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.12
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.12
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.05
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 3.0
RNA-seq differential expression studies: more sequence, or more replication? 2.98
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.98
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 2.93
miR-93 Targets in Human Endothelial Cells 2.92
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.92
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 2.88
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 2.87
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.87
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.86
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 2.82
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 2.81
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 2.78
2.78
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.77
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.77
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.75
Impact on erythroid progenitor type on erythroid differntiation 2.75
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 2.75
Recovery and analysis of nascent RNA 2.75
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.73
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 2.72
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 2.7
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 2.69
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 2.68
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.68
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.61
UV_24h_GRO-Seq 2.59
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.58
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.51
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 2.5
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.5
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.5
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 2.44
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 2.38
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.37
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.37
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 2.36
KLF6-dependent transcription in renal cancer cells 2.35
Targeted enhancer activation by a subunit of the integrator complex 2.33
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.29
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 2.27
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.24
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 2.21
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 2.16
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 2.11
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 2.09
Widespread regulated alternative splicing of single codons accelerates proteome evolution 2.09
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.08
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 2.05
Ribosome profiling upon inhibition of eIF4A 2.03
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.02
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 2.02
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.0
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.95
The pioneer factor CEBPA modulates vitamin D signaling 1.91
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 1.91
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 1.91
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 1.91
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 1.89
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 1.89
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.87
Effect of ILF3 on translation during homeostasis and the antiviral response 1.86
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.81
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 1.77
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 1.77
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.74
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.74
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 1.73
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.72
MicroRNA-125a-5p overexpression in human macrophages 1.7
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.7
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 1.68
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 1.67
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.63
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 1.61
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.61
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.53
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 1.51
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.51
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.5
Energy Metabolism during Anchorage-Independence 1.49
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.47
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 1.46
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.45
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 1.43
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 1.39
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 1.39
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.38
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 1.37
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.36
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.36
Interaction between mitoNEET and NAF-1 in cancer cells 1.35
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 1.33
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.31
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.3
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.27
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.27
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 1.21
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 1.21
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 1.21
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.21
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.19
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.17
Illumina Total RNA-seq in HeLa 1.15
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.15
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.12
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.12
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.12
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.1
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.09
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 1.07
Differences in miRNA Detection Levels are Technology and Sequence Dependent 1.07
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 1.07
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 1.07
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.07
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.06
The bromodomain protein BRD4 regulates splicing during heat shock 1.04
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.03
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.03
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.03
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 1.01
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.99
Comparative Analysis of Cas9 Activators Across Multiple Species 0.97
Expression profiling of MCF-7 cells with treatment of TCDD 0.96
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.96
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.94
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.92
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.91
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.89
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.88
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.88
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.86
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.86
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.86
Ribosomal protein RPL26 is the principal target of UFMylation 0.85
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.84
Iron response of HepG2 cells 0.78
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.75
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.73
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.71
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.69
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.69
Gene expression analysis of human adenomas. 0.69
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.66
Gene expression activation in CLL mediated by MSCs contact 0.65
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.62
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.62
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.6
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.59
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.56
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.54
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.54
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.54
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.53
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.53
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.53
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.5
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 0.5
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.49
Solid phase chemistry to covalently and reversibly capture thiolated RNA 0.48
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.48
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.48
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.46
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.45
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.43
Determining mRNA half-lives on a transcriptome-wide scale 0.43
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.4
Induced DNA demethylation, genome instability and transcription 0.38
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 0.38
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.35
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.35
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.35
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.35
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.33
K562 polyA RNA-Seq 0.32
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.31
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.31
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.3
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.3
Transposon-based construction of strand-specific RNA-seq libraries 0.28
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.26
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.26
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.25
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.2
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.18
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.16
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.16
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.14
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.14
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.14
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.14
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 0.14
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.13
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 0.12
ChIP-seq and RNA-seq from human lymphoma cell lines 0.11
RNA-seq data from human lymphoma cell lines 0.11
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.08
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.08
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 0.07
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 0.07
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.07
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.06
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.05
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.04
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.04
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.03
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.03
Gene expression analysis upon mtDNA depletion 0.03
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.02
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation